TAGLN and gastric cancer: We mixed TAGLN siRNA CAFs, non-silenced CAFs, CPFs and NFs with MKN-45 human gastric cancer cells in a 2:1 ratio or MKN-45 alone and inoculated these cells through tail intravenous injection in immunodeficient nude mice.